ロード中...
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
BACKGROUND AND AIM: Currently, sorafenib is indicated for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM), and many other systemic agents are becoming available. However, a few HCC patients with EHM still undergo transarterial chemoembolization (TACE) for intrahepatic tumor control...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6405107/ https://ncbi.nlm.nih.gov/pubmed/30845192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0213547 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|